![B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets - Thomas G. Forsthuber, Daniel M. Cimbora, John Nolan Ratchford, Eliezer Katz, Olaf Stüve, 2018 B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets - Thomas G. Forsthuber, Daniel M. Cimbora, John Nolan Ratchford, Eliezer Katz, Olaf Stüve, 2018](https://journals.sagepub.com/cms/10.1177/1756286418761697/asset/images/large/10.1177_1756286418761697-fig1.jpeg)
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets - Thomas G. Forsthuber, Daniel M. Cimbora, John Nolan Ratchford, Eliezer Katz, Olaf Stüve, 2018
![CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F2162-3619-1-36/MediaObjects/40164_2012_Article_34_Fig1_HTML.jpg)
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
![B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram](https://www.researchgate.net/publication/313232213/figure/fig2/AS:457339691114499@1486049687549/B-cell-lineage-and-surface-marker-expression-A-diagram-of-a-simplified-development-and.png)
B cell lineage and surface marker expression. A diagram of a simplified... | Download Scientific Diagram
![B cell CD markers. The B cell maturation process involves two phases of... | Download Scientific Diagram B cell CD markers. The B cell maturation process involves two phases of... | Download Scientific Diagram](https://www.researchgate.net/publication/358724802/figure/fig1/AS:1184949327671296@1659525343010/B-cell-CD-markers-The-B-cell-maturation-process-involves-two-phases-of.png)
B cell CD markers. The B cell maturation process involves two phases of... | Download Scientific Diagram
![Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations](https://www.frontiersin.org/files/MyHome%20Article%20Library/484200/484200_Thumb_400.jpg)
Frontiers | Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations
![Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrclinonc.2013.46/MediaObjects/41571_2013_Article_BFnrclinonc201346_Fig1_HTML.jpg)
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
![Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor β 1 in human peripheral blood Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor β 1 in human peripheral blood](https://www.archivesofmedicalscience.com/f/fulltexts/93831/AMS-15-33534-g002.jpg)
Phenotypic identification of CD19+CD5+CD1d+ regulatory B cells that produce interleukin 10 and transforming growth factor β 1 in human peripheral blood
![B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41571-022-00619-z/MediaObjects/41571_2022_619_Fig1_HTML.png)
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
![IJMS | Free Full-Text | In Vitro Characterization of Human CD24hiCD38hi Regulatory B Cells Shows CD9 Is Not a Stable Breg Cell Marker IJMS | Free Full-Text | In Vitro Characterization of Human CD24hiCD38hi Regulatory B Cells Shows CD9 Is Not a Stable Breg Cell Marker](https://pub.mdpi-res.com/ijms/ijms-22-04583/article_deploy/html/images/ijms-22-04583-g001-550.jpg?1619522865)